Leave Your Message

Lipid Management/ZC-SLM/Probiotics Premix/500B

Shelf life: 24 months

Storage conditions: Stored at -18℃ or below

Main Strains
  • Bifidobacterium animalis subsp. lactis F1-7
  • Lactiplantibacillus plantarum YZX21
  • Lacticaseibacillus paracasei G15
  • Lactiplantibacillus plantarum F3-2
  • Bifidobacterium animalis subsp. lactis BA-C53
  • Lacticaseibacillus paracasei X11

Health Benefits

Lipid Management ZC-SLM Probiotics Premix 500B

√ Improve blood glucose metabolism and assist in the treatment of type 2 diabetes

√ Improve lipid metabolism

√ Improve high density and low density cholesterol content

√ Improve atherosclerosis

√ Help improve hypertension

Three-dimensional interventions (body fat, visceral fat, lipids)


Three-dimensional interventions

The advantages of probiotics in fat-lowering


The advantages of probiotics in fat-lowering

Enhancing levels of GLP-1 and PYY, upregulating the glucagon gene, and bidirectionally regulating blood glucose.


Enhancing levels of GLP-1 and PYY,

Lactiplantibacillus plantarum F3-2 showed significant improvement in body fat


NC:control group HFD:fatty liver group OR:orlistat group F3-2:probiotic group

Lactiplantibacillus plantarum F3-2 showed significant improvement in body fat

The data presented in the figure indicates that after a period of feeding, the body weight of mice in the high-fat diet group significantly increased compared to the control group. In contrast, the weight gain observed in mice subjected to Lactiplantibacillus plantarum F3-2 intervention was markedly lower than that of the high-fat diet group. This clearly demonstrates the positive regulatory effect of Lactiplantibacillus plantarum F3-2 on obesity induced by a high-fat diet.

Reference: Lactiplantibacillus plantarum F3-2 and mannooligosaccharides alleviated the obesity of mice through up-regulating SCFAs and inhibiting PPARγ Experimental Study on Lactiplantibacillus plantarum F3-2.

Reduce the size of fat cells and relieve excessive fat accumulation Experimental Study on Lactiplantibacillus plantarum F3-2


NC: Control group HFD: High-fat diet group OR: Orlistat group Plant F3-2: Probiotic group

Experimental Study on Lactiplantibacillus plantarum F3-2

Conclusion:

F3-2, repair s fatt y l i ver and restores hepatic lipid-processing function, similar to the positive drug orlistat.

Reference: A strain of Lactiplantibacillus plantarum F3-2 and its application

H-87 inhibits the enlargement of adipocytes and reduces body fat


NLow-fat diet feeding group (LFD), high-fat diet feeding group (HFD), probiotic + high fat diet group (H-87)

H-87 inhibits the enlargement of adipocytes and reduces body fat

Reference: Lactiplantibacillus plantarum H-87 prevents high-fat diet-induced obesity by regulating bile acid metabolism in C57BL/6J mice.

H-87 reduces liver lipogenesis


H-87 reduces liver lipogenesis

Reference: Lactiplantibacillus plantarum H-87 prevents high-fat diet-induced obesity by regulating bile acid metabolism in C57BL/6J mice.

Experimental Study on Lactiplantibacillus plantarum H-87

Low-fat diet fed group (LFD), high-fat diet fed group (HFD), probiotics + high-fat diet group (H-87)

A high-fat diet significantly increases liver weight and triglyceride (TG) levels, while H-87 supplementation can markedly reduce liver weight, liver TG, and cholesterol (CHOL) in mice subjected to a high-fat diet, thereby decreasing hepatic fat accumulation.

Lower total cholesterol and triglyceride levels


Experimental Study on Lacticaseibacillus paracasei G1

Normal control group (N); Diabetic control group (D); Metformin treated group (M); Lacticaseibacillus G15 treated group (G); Lacticaseibacillus Q14 treated group (Q)

Lower total cholesterol and triglyceride levels

Experimental conclusion:

G15 reduces serum triglycerides andtotal cholesterol levels, modulates bloodlipids, and stabilizes body lipidmetabolism.

Leave Your Message